Christina Lake Cannabis Corp. (C:CLC)
Business Focus: Recreational Pharmaceuticals
| Sector: Healthcare | Industry: Pharmaceuticals |
| Company Contact | |
| Address: | 789 West Pender Street, Suite 810 VANCOUVER BC V6C 1H2 |
| Tel: | N/A |
| Website: | www.clcannabis.com |
| IR: | See website |
| Key People | ||
| N/A | ||
| Business Overview |
| Christina Lake Cannabis Corp. is a Canada-based licensed producer of cannabis. The Company is a licensed cannabis producer with a cultivation, processing, research and development, and sales license from Health Canada. The Company is engaged in the processing of its stock of dried cannabis biomass into various extracts, including distilled and winterized oils, kief, and additional extracted products for sale to other licensed producers. The Company focuses its production on creating extracts and distillate for its business-to-business (B2B) client base, with strains specifically developed for outdoor cultivation to enhance extraction quality. Its facility consists of an approximately 32-acre property, which includes over 950,000 square feet of outdoor grow space, offices, propagation and drying rooms, research facilities, and a facility dedicated to processing and extraction. The Company also owns about a 99-acre plot of land adjoining its principal site. |
| Financial Overview |
| For the six months ended 31 May 2023, Christina Lake Cannabis Corp revenues increased 36% to C$5.4M. Net loss increased from C$362K to C$2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Gain on settlement decrease from C$259K (income) to C$0K, Salaries increase of 21% to C$916K (expense), Interest Expense increase of 72% to C$370K (expense). |
| Reporting Currency: | Canadian Dollars |
| Enterprise value: | $9.20M as of May 31, 2023 |
| Annual revenue (TTM): | $11.49M as of May 31, 2023 |
| EBITDA (TTM): | -$6.58M as of May 31, 2023 |
| Net annual income (TTM): | -$3.65M as of May 31, 2023 |
| Free cash flow (TTM): | -$0.10M as of May 31, 2023 |
| Net Debt Last Fiscal Year: | $4.89M as of May 31, 2023 |
| Shares outstanding: | 131,122,174 as of May 31, 2023 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
US Quotes Data provided by IEX. Additional price data powered by Twelve Data. Company fundamental sourced from © Refinitiv. Click for restrictions. © Refinitiv. All rights reserved. Republication or redistribution of Refinitiv, including by framing or similar means, is prohibited without the prior written consent of Refinitiv. Refinitiv is not liable for any errors or delays in Refinitiv content, or for any actions taken in reliance on such content.
Interactive technical study charts by TradingView. Copyright © 2023 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.